Therefore, there are co-ordinated alterations to two surface markers (PD1 and CCR6) that appear to be specific to the circulating CD4+CD45RA-CXCR5+ T-cells of MZL and BNHL patients. The gene discussed is CCR6; the disease is marginal zone lymphoma.